These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 8979662)

  • 21. Efficacy of dapiprazole with hydroxyamphetamine hydrobromide and tropicamide.
    Johnson ME; Molinari JF; Carter J
    J Am Optom Assoc; 1993 Sep; 64(9):629-33. PubMed ID: 7901258
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Does prior instillation of a topical anaesthetic alter the pupillary mydriasis produced by tropicamide (0.5%)?
    Haddad DE; Rosenfield M; Portello JK; Krumholz DM
    Ophthalmic Physiol Opt; 2007 May; 27(3):311-4. PubMed ID: 17470245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A double-blind study comparing 0.5% and 1% tropicamide for annual retinal screening in diabetic adolescents.
    Hassler-Hurst J; Wadham C; Rayman G
    Diabet Med; 2004 May; 21(5):434-9. PubMed ID: 15089787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative study of the effects of 2% ibopamine, 10% phenylephrine, and 1% tropicamide on the anterior segment.
    Marchini G; Babighian S; Tosi R; Perfetti S; Bonomi L
    Invest Ophthalmol Vis Sci; 2003 Jan; 44(1):281-9. PubMed ID: 12506086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mydriasis with different preparations of topically administered lidocaine hydrochloride.
    Claesson M; Johansson M; Behndig A
    J Cataract Refract Surg; 2009 Feb; 35(2):277-81. PubMed ID: 19185243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mist delivery of eye medication to the anterior segment.
    Collins JF; Dartt DA; Dana R
    Am J Ophthalmol; 2007 Jul; 144(1):137-9. PubMed ID: 17601439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combination of 5% phenylephrine and 0.5% tropicamide eyedrops for pupil dilation in neonates is twice as effective as 0.5% tropicamide eyedrops alone.
    Lux AL; Degoumois A; Barjol A; Mouriaux F; Denion E
    Acta Ophthalmol; 2017 Mar; 95(2):165-169. PubMed ID: 27519933
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Phentolamine Eye Drops Reverse Pharmacologically Induced Mydriasis in a Randomized Phase 2b Trial.
    Karpecki PM; Foster SA; Montaquila SM; Kannarr SR; Slonim CB; Meyer AR; Sooch MP; Jaber RM; Charizanis K; Yousif JE; Klapman SA; Amin AT; McDonald MB; Horn GD; Lazar ES; Pepose JS
    Optom Vis Sci; 2021 Mar; 98(3):234-242. PubMed ID: 33633016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison between obtained mydriasis in type 2 diabetics and non-diabetic patients.
    Coblentz J; Motta MM; Fernandes BF; Burnier MN; Vianna RN
    Curr Eye Res; 2009 Nov; 34(11):925-7. PubMed ID: 19958108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A pre-operative mydriatic regime using a single application of tropicamide Novel Ophthalmic Delivery System and guttae phenylephrine 10%.
    Patel CK; Bui TA; Gregariou G; Pereira S; Chopdar A; McLeod BK
    Eye (Lond); 1995; 9 ( Pt 3)():337-40. PubMed ID: 7556743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pupillographic evaluation of the mydriatic effect of ibopamine solution.
    Gelmi C; Palazzuolo A; Lucchetti M; Trimarchi F
    Int J Clin Pharmacol Ther Toxicol; 1989 Jul; 27(7):346-51. PubMed ID: 2777423
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacodynamics of a new ophthalmic mydriatic insert in healthy volunteers: potential alternative as drug delivery system prior to cataract surgery.
    Mouly S; Mahé I; Haouchine B; Sanson-le-Pors MJ; Blain P; Tillet Y; Dewailly J; Mongold JJ; Bergmann JF
    Basic Clin Pharmacol Toxicol; 2006 Jun; 98(6):547-54. PubMed ID: 16700815
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Minimizing risk of adverse reactions to mydriatic agents in binocular indirect ophthalmoscopy.
    Levine L
    J Am Optom Assoc; 1985 Jul; 56(7):542-8. PubMed ID: 4020007
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination cyclopentolate and phenylephrine for mydriasis in premature infants with heavily pigmented irides.
    Khoo BK; Koh A; Cheong P; Ho NK
    J Pediatr Ophthalmol Strabismus; 2000; 37(1):15-20. PubMed ID: 10714690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of commercial dilating agents on laser flare-cell measurements.
    Chin PK; Cuzzani OE; Gimbel HV; Sun R
    Can J Ophthalmol; 1996 Dec; 31(7):362-5. PubMed ID: 8971457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of 2% ibopamine on the dilation of patients with pseudoexfoliation syndrome.
    Scuderi GL; Regine F; Perdicchi A; Turtoro A; Contestabile MT
    Eur J Ophthalmol; 2010; 20(1):120-3. PubMed ID: 19882519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of drop size of cyclopentolate, phenylephrine and tropicamide on pupil dilatation and systemic side effects in infants.
    Elibol O; Alçelik T; Yüksel N; Caglar Y
    Acta Ophthalmol Scand; 1997 Apr; 75(2):178-80. PubMed ID: 9197568
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Effects of three madriatics on the human ocular aberrations].
    Yu J; Chen H; Hu JY; Xun PC
    Zhonghua Yan Ke Za Zhi; 2005 Sep; 41(9):826-31. PubMed ID: 16191351
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimizing the intracameral dilation regimen for cataract surgery: prospective randomized comparison of 2 solutions.
    Myers WG; Shugar JK
    J Cataract Refract Surg; 2009 Feb; 35(2):273-6. PubMed ID: 19185242
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of potentiating effect of a drop of lignocaine on tropicamide-induced mydriasis.
    Ghose S; Garodia VK; Sachdev MS; Kumar H; Biswas NR; Pandey RM
    Invest Ophthalmol Vis Sci; 2001 Jun; 42(7):1581-5. PubMed ID: 11381064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.